MICHELLE A FANALE to Leukemia, Lymphocytic, Chronic, B-Cell
This is a "connection" page, showing publications MICHELLE A FANALE has written about Leukemia, Lymphocytic, Chronic, B-Cell.
Connection Strength
0.067
-
Long-term overall- and progression-free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non-Hodgkin lymphoma. Br J Haematol. 2019 05; 185(4):670-678.
Score: 0.067